258 related articles for article (PubMed ID: 22870484)
1. Novel treatments for systemic lupus erythematosus.
Xiong W; Lahita RG
Ther Adv Musculoskelet Dis; 2011 Oct; 3(5):255-66. PubMed ID: 22870484
[TBL] [Abstract][Full Text] [Related]
2. B-cell-targeted therapy for systemic lupus erythematosus.
Sabahi R; Anolik JH
Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
[TBL] [Abstract][Full Text] [Related]
3. Belimumab: anti-BLyS human monoclonal antibody, anti-BLyS monoclonal antibody, BmAb, human monoclonal antibody to B-lymphocyte stimulator.
Drugs R D; 2008; 9(3):197-202. PubMed ID: 18457473
[TBL] [Abstract][Full Text] [Related]
4. Novel treatments for systemic lupus erythematosus.
Gayed M; Gordon C
Curr Opin Investig Drugs; 2010 Nov; 11(11):1256-64. PubMed ID: 21157645
[TBL] [Abstract][Full Text] [Related]
5. Treatment of systemic lupus erythematosus: new advances in targeted therapy.
Lo MS; Tsokos GC
Ann N Y Acad Sci; 2012 Jan; 1247():138-52. PubMed ID: 22236448
[TBL] [Abstract][Full Text] [Related]
6. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.
Harvey PR; Gordon C
BioDrugs; 2013 Apr; 27(2):85-95. PubMed ID: 23456653
[TBL] [Abstract][Full Text] [Related]
7. Breaking the ice in systemic lupus erythematosus: belimumab, a promising new therapy.
Mosak J; Furie R
Lupus; 2013 Apr; 22(4):361-71. PubMed ID: 23553779
[TBL] [Abstract][Full Text] [Related]
8. Biologics in SLE: the current status.
Rajadhyaksha AG; Mehra S; Nadkar MY
J Assoc Physicians India; 2013 Apr; 61(4):262-7. PubMed ID: 24482965
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE).
Ponticelli C; Moroni G
Pharmaceuticals (Basel); 2010 Jan; 3(1):300-322. PubMed ID: 27713252
[TBL] [Abstract][Full Text] [Related]
10. B-cell-directed therapies in systemic lupus erythematosus.
Tieng AT; Peeva E
Semin Arthritis Rheum; 2008 Dec; 38(3):218-27. PubMed ID: 18206214
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of novel B cell biologics as the future of SLE treatment: a review.
Kamal A; Khamashta M
Autoimmun Rev; 2014 Nov; 13(11):1094-101. PubMed ID: 25149393
[TBL] [Abstract][Full Text] [Related]
12. Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol.
Teng YKO; Bruce IN; Diamond B; Furie RA; van Vollenhoven RF; Gordon D; Groark J; Henderson RB; Oldham M; Tak PP
BMJ Open; 2019 Mar; 9(3):e025687. PubMed ID: 30898822
[TBL] [Abstract][Full Text] [Related]
13. Belimumab in systemic lupus erythematosus: an update for clinicians.
Kim SS; Kirou KA; Erkan D
Ther Adv Chronic Dis; 2012 Jan; 3(1):11-23. PubMed ID: 23251765
[TBL] [Abstract][Full Text] [Related]
14. Belimumab: review of use in systemic lupus erythematosus.
Boyce EG; Fusco BE
Clin Ther; 2012 May; 34(5):1006-22. PubMed ID: 22464040
[TBL] [Abstract][Full Text] [Related]
15. Management of Pediatric Systemic Lupus Erythematosus: Focus on Belimumab.
Guzman M; Hui-Yuen JS
Drug Des Devel Ther; 2020; 14():2503-2513. PubMed ID: 32612353
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial.
van Schaik M; Arends EJ; Soonawala D; van Ommen E; de Leeuw K; Limper M; van Paassen P; Huizinga TWJ; Toes REM; van Kooten C; Rotmans JI; Rabelink TJ; Teng YKO
Trials; 2022 Nov; 23(1):939. PubMed ID: 36371234
[TBL] [Abstract][Full Text] [Related]
17. [What's new in internal medicine: emerging treatments for systemic lupus erythematosus].
Hachulla É
Ann Dermatol Venereol; 2011 Dec; 138 Suppl 4():S241-4. PubMed ID: 22202645
[TBL] [Abstract][Full Text] [Related]
18. Successful sequential therapy with rituximab and belimumab in patients with active systemic lupus erythematosus: a case series.
Gualtierotti R; Borghi MO; Gerosa M; Schioppo T; Larghi P; Geginat J; Meroni PL
Clin Exp Rheumatol; 2018; 36(4):643-647. PubMed ID: 29533753
[TBL] [Abstract][Full Text] [Related]
19. Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases.
Gupta S; Tatouli IP; Rosen LB; Hasni S; Alevizos I; Manna ZG; Rivera J; Jiang C; Siegel RM; Holland SM; Moutsopoulos HM; Browne SK
Arthritis Rheumatol; 2016 Jul; 68(7):1677-87. PubMed ID: 26815287
[TBL] [Abstract][Full Text] [Related]
20. Belimumab: a BLyS-specific inhibitor for systemic lupus erythematosus.
Wiglesworth AK; Ennis KM; Kockler DR
Ann Pharmacother; 2010 Dec; 44(12):1955-61. PubMed ID: 21081710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
